← FDA Drug Approvals (Drugs@FDA)

OXALIPLATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM HAINAN · Approved 2016-06-07

Drug application

FDA Application #

ANDA204368

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXALIPLATIN

Generic name

OXALIPLATIN

Active ingredients

OXALIPLATIN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

QILU PHARM HAINAN

Manufacturer

Qilu Pharmaceutical Co., Ltd.

First approval

2016-06-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown